Professional Care
Testing
The BD Veritor(TM) Plus System enhances point-of-care testing for SARS-CoV-2, SARS-CoV-2 & Flu A+B,* Flu A+B, Group A Strep, and RSV, providing rapid diagnostic testing in a convenient, portable instrument.
Contact Us
Our Available Assays
Once you have bought the BD Veritor™ Plus Analyzer, you can then order various compatible assays to deliver reliable respiratory infection testing.
COVID-19 & Flu
Flu A+B
RSV
Group A Strep
The BD Veritor™ Plus System
The BD Veritor™ Plus System is a point-of-care testing solution for SARS-CoV-2, SARS-CoV-2 & Flu A+B,* Flu A+B, Group A Strep, and RSV. It offers:
- The BD Veritor™ Plus Analyzer, a simple, easy-to-use device that delivers unambiguous, rapid and reliable digital results.
- A range of assays to aid clinicians in the diagnosis and management of multiple respiratory infections for symptomatic patients so they can take their next steps with more confidence.
Contact a Sales Representative to get your organization’s
diagnostic testing program started today
Invest in simplicity
Digital Clarity
Unambiguous positive/negative display which may help to reduce result interpretation errors and streamline diagnosis.
Rapid results
Delivers digitally read results in 15 minutes or less,** supporting timely clinical decisions.
Easy to use
No monthly calibration required, operated with single-button functionality.
Cost effective
No service contracts, maintenance or calibration needed for device lifetime.
How It Works
The BD Veritor™ Plus System provides an easy sample-collection process that can be incorporated across a variety of clinical settings.
Step 1: Collect sample
Step 2: Mix the swab with the reagent vial
Step 3: Prepare assay with the sample
Step 4: Run the test
Step 5: Insert the cartridge and read the results
BD Veritor™ Plus System Support & Training
See how BD supports you with tools, education, and training—enabling a streamlined point-of-care experience for those you serve, and confidence in your results.
Buying Options
Order the BD Veritor™ Plus Analyzer and system accessories. Browse our CPT codes for various rapid antigen assays, including Flu and COVID-19.
RSV=respiratory syncytial virus; SARS-CoV-2=severe acute respiratory syndrome coronavirus 2.
*In the USA, the BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B has not been FDA cleared or approved but has been authorized by the FDA under an Emergency Use Authorization for use by authorized laboratories; use by laboratories certified under the CLIA, 42 U.S.C. §263a, that meet requirements to perform moderate, high, or waived complexity tests. The product is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
This product has been authorized only for the detection of proteins from SARS-CoV-2, influenza A and influenza B, not for any other viruses or pathogens; and, in the USA, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID 19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
**Result processing times for each BD Veritor™ assay are 15 minutes for the SARS-CoV-2 and SARS-CoV-2 & Flu A+B assays, 10 minutes for Flu A+B and RSV assays, and 5 minutes for the Group A Strep assay.
BD, the BD Logo, and BD Veritor are trademarks of Becton, Dickinson and Company or its affiliates. © 2026 BD. All rights reserved.
bd.com